Dr Avencia Sánchez-Mejías, co-founder and CEO of Integra Therapeutics, won the first edition of the Women and Leadership Award promoted by Deusto Business School, Cinco Días and Banco  Santander to boost  and raise awareness of the talent of female executives at companies and in entrepreneurship. The ceremony was held on 2 June at the business school’s Madrid (Spain) headquarters.

Sánchez-Mejías was chosen from among more than 80 candidates. “I’m accepting this award with a great sense of responsibility and I hope to be a role model for women, and men too, from the coming generations. It is also a ...

Ysios Capital has announced the participation in the financing round of the US company Mineralys Therapeutics, for a total  amount of $118 million. This is the tenth investment of Ysios Capital's third fund, Ysios BioFund III, and the first in the US. For this operation, Ysios has joined an international investment syndicate led by RA Capital Management and Andera Partners. The fund manager, a member of CataloniaBio &  HealthTech, expects to close two more new investments before the end of  the year.

Sustainability is gaining momentum in business and is a factor that increases the value of the companies that strive to achieve it. CataloniaBio & HealthTech’s last Lessons Learned conference, on May 31, at ESADE Creapolis (Sant Cugat), put the focus on sharing experiences in establishing sustainable practices in companies in the sector. Specifically, on how to extend these practices to suppliers, which is one of the most important challenges they face.

The Centre for Comparative Medicine and Bioimage (CMCiB) of the Germans Trias i Pujol Research Institute, a CataloniaBio &HealthTech member, has been awarded the certificate for complying with good laboratory practices (GLP) in line with the European Directive 2004/9/CE. The centre complies with the principles established by the Spanish Royal Decree822/19932 for carrying out preclinical studies with healthcare products (analytical tests, clinical chemistry - haematology and biochemistry - in studies administrating trial products, obtaining samples and biocompatibility of healthcare products). The areas certified are the surgical and bioimage areas, including the technology of vascular radiology interventions, ultrasound scan and magnetic resonance.

Minoryx Therapeutics, a Phase III biotechnology company that develops treatments for minority or rare diseases of the Central Nervous System (CNS), and a CataloniaBio & HealthTech  member, has announced that it has secured 51 million euros of investment in a new capital increase (Series C) and complementary bank debts.

Mitelos started its journey in the market by the end of 2016 with the commercialisation of its first product. A little over 5 years later Mitelos has just reached  sales of 2 million units of their ear health franchise comprising two  solutions-based medical devices. To date, Mitelos ear care products are Otiblock® for the treatment and prevention of earwax impaction and Otidry-MD® for the prevention of acute otitis externa (“swimmer's ear”).

CataloniaBio  & HealthTech has appointed Javier Selva as CEO of the association to lead its growth and continue to promote the representation of companies in the biomedicine and health sector in Catalonia. Selva will work together with the new board chaired by Joan Puig de Dou, CEO of Kymos, from February 2022, which has concluded this selection process already started by the previous board.

17 Catalan clusters have travelled to Boston this past week with the aim of exploring strategic opportunities within their sectors, fostering international networking and learning about how clusters work in advanced and innovative ecosystems. This trip is part of the Strategic Cluster Week, an initiative organized by ACCIÓ through the Catalonia  Clusters programme, in collaboration with the Foreign Trade and Investment Office in New York. CataloniaBio & HealthTech is one of the clusters that has participated in the initiative.

Abzu was mentioned this May in an article by the Oligonucleotide Therapeutics Society, a US non-profit dedicated to foster academia and industry-based R&D in oligonucleotide therapeutics.

Aptadel Therapeutics, juntament amb les empreses biotecnològiques de la UE, iCellate i Anapharm, ha rebut una beca Eurostars per una teràpia dirigida basada en aptòmers d’ARN i un diagnòstic complementari per al Sacroma d’Ewing (ES).

Devicare, one of the leading biotechnology companies in urology in Spain and a CataloniaBio & HealthTech  member, presents to the market the first app designed specifically for patients with renal lithiasis. myLit-Control®  App allows patients to make a personalized follow-up of their pathology through daily monitoring, access to educational content, the possibility of receiving discounts on the purchase of products and participating in challenges aimed at changing their habits.

This project  begins with the entry of Advanced Medtech Holdings into the capital of Devicare  in 2020, with the aim of promoting the digital area of Devicare. In these two years ...

Nuage Therapeutics has appointed Judit Anido as CEO of the company to lead its growth and support the development of drugs that modulate therapeutic targets currently considered undruggable, in order to to improve patients’ lives.

Sidekick Health ha anunciat el tancament d’una ronda de finançament de Serie B de 55 milions de dòlars. La ronda l’ha liderat la firma londinenca d’inversió Novator Ventures, amb la participació de Sabadell Asabys, Wellington Partners i Frumtak Ventures, i ha comptat també amb l’entrada d’un corporatiu estratègic americà que serà anunciat més endavant.

Integra Therapeutics, a biotechnology company that creates next-generation gene writing tools, member of CataloniaBio & HealthTech, announced today that Dr Mark Bonyhadi has been appointed to its Board of Directors as an independent director.

The President of the Generalitat de Catalunya, Pere Aragonès, has inaugurated the Avinent Hub, the new  innovation and production center of the Avinent group, a leading company in the manufacture of products with the highest demand for the medical sector. The new building, of 8,000 m2 and which has involved an investment of € 10 million, reflects the ambition, modernity, and technological spirit of the Catalan firm, based in Santpedor. This expansion aims to ensure the future capacity for business growth and go from € 35 million in turnover in the last year to € 50 million in 2025.

Laboratoris Reig Jofre, l’empresa farmacèutica cotitzada al mercat continu de la borsa espanyola i membre de CataloniaBio & HealthTech, ha rebut la visita del president de la Generalitat de Catalunya, Pere Aragonès, a la seva nova planta d’última generació de productes injectables d’ús hospitalari. L’acte ha comptat també amb la participació de la presidenta i el conseller delegat de Reig Jofre, Isabel Reig i Ignasi Biosca, i de l’alcaldessa de Sant Joan Despí, Belén García.

Ditec Medical, a specialist in the digitization of operating theatres with a link to the audiovisual sector, has just launched its own line of multimedia medical carts for the health sector. A new generation of high-performance, state-of-the-art solutions that are easy to use for the general public.

The biotechnology company Onalabs, a member of CataloniaBio & HealthTech, has closed its first round of financing, raising 1.2 million euros. The company, dedicated to the development of medical devices capable of monitoring the physical and biochemical parameters of the skin, has carried out the round through the crowdfunding platform Capital Cell, also a member.

The consultancy firm GENESIS Biomed, CataloniaBio & HealthTech  member, together with FI Group, have created GENESIS Tech Transfer Boost, a new investment vehicle initially endowed with €1M that will invest in early-stage projects in the field of health research.

Mediktor, the AI medical assistant for triage and pre-diagnosis, has appointed Amit Jain as Chairman of the board. He will be actively involved in developing and guiding Mediktor’s commercial strategy for the US Market.